Cargando…
Multiomics integrative analysis for gene signatures and prognostic values of m(6)A regulators in pancreatic adenocarcinoma: a retrospective study in The Cancer Genome Atlas project
N6-methyladenosine(m(6)A) is the most abundant post-transcriptional RNA modification in eukaryotes. However, little is known about its role in pancreatic adenocarcinoma (PAAD). The aim of our study was to identify gene signatures and prognostic values of m(6)A regulators in PAAD. Patients from 3 dif...
Autores principales: | Gao, Wenzhe, Cheng, Liuyang, He, Shuhan, Li, Wei, Zhou, Chengyu, Zhou, Bixia, Liu, Jiamiao, Xu, Jiahao, Yu, Xiao, Zhu, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655159/ https://www.ncbi.nlm.nih.gov/pubmed/33082301 http://dx.doi.org/10.18632/aging.103942 |
Ejemplares similares
-
Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021) -
Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022) -
Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022) -
Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma
por: Fan, Xiaoying, et al.
Publicado: (2022) -
Identification of EMT-Related lncRNAs as Potential Prognostic Biomarkers and Therapeutic Targets for Pancreatic Adenocarcinoma
por: Deng, Yanyao, et al.
Publicado: (2022)